Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Sera Prognostics Inc (SERA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Sera Prognostics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
10.63 +0.20    +1.92%
02/05 - Closed. Currency in USD ( Disclaimer )
After Hours
10.75
+0.12
+1.13%
21:53:13 - Real-time Data
  • Volume: 67,876
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 10.17 - 10.86
Type:  Equity
Market:  United States
Sera Prognostics 10.63 +0.20 +1.92%

Sera Prognostics Company Profile

 
Read the Sera Prognostics Inc company profile to learn more about the business and the management team. View Sera Prognostics Inc facts about employee data, company products and services, and contact information.
IndustryProfessional & Commercial Services
SectorIndustrials
Employees

88

Equity Type

ORD

Sera Prognostics, Inc., a women’s health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Contact Information

Address 2749 East Parleys Way Suite 200
Salt Lake City, 84109
United States
Phone 801 990 0520
Fax 801 990 6601

Top Executives

Name Age Since Title
Kim Puloma Kamdar 56 2011 Independent Chairman
Jane F. Barlow 62 2022 Independent Director
Evguenia Lindgardt 49 2021 President, CEO & Director
Robert M. Silver - - Member of Scientific Advisory Board
Robert H. Getzenberg - - Member of Scientific Advisory Board
Amos E. Madanes - - Member of Scientific Advisory Board
D. Ware Branch - - Member of Scientific Advisory Board
C. Matthew Peterson - - Member of Scientific Advisory Board
Joshua S. Phillips 57 2011 Independent Director
David G. Grenache - - Member of Scientific Advisory Board
Gregory C. Critchfield 71 2011 Executive Director
Steven W. Graves - 2008 Co-Founder and Co-Chairman of The Scientific Advisory Board
Ryan Melroy Trimble 72 2011 Independent Director
M. Sean Esplin - 2008 Co-Founder and Co-Chairman of Scientific Advisory Board
Mansoor Raza Mirza 63 2014 Independent Director
Marcus Dean Wilson 61 2021 Independent Director
Sandra A. J. Lawrence 66 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SERA Price Commentary

Write your thoughts about Sera Prognostics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email